Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kanchi KarpooramBOM:538896 73 EBITDA Margin % is 5.69% as of Mar. 2026, which is 65% below its 10-year median of 16.37. GuruFocus rates BOM:538896 with a GF Score™ of 73/100 and a GF Value™ of ₹379.34 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,578 Chemicals companies, Kanchi Karpooram ranks worse than 55.77% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Kanchi Karpooram's EBITDA for the
three
months ended in Mar. 2026 was ₹23 Mil. Kanchi Karpooram's Revenue for the
three
months ended in Mar. 2026 was ₹402 Mil. Therefore, Kanchi Karpooram's EBITDA margin for the quarter that ended in Mar. 2026 was 5.69%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Kanchi Karpooram EBITDA Margin % Related Terms
Kanchi Karpooram EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Kanchi Karpooram's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:538896 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Kanchi Karpooram's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kanchi Karpooram EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Kanchi Karpooram's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Kanchi Karpooram's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kanchi Karpooram (BOM:538896) has a EBITDA Margin % of 5.69% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kanchi Karpooram and its competitors. This is 65% below median its historical median of 16.37. Over the past decade, Kanchi Karpooram's EBITDA Margin % has ranged from 2.42 to 45.46. According to the industry distribution chart, Kanchi Karpooram ranks #880 out of 1578 companies in the Chemicals industry, placing it in the top 55.8%.
Is Kanchi Karpooram's EBITDA Margin % too high?
Kanchi Karpooram's current EBITDA Margin % of 5.69% is 65% below median its 10-year median of 16.37. Over the past 10 years, this metric has ranged from a low of 2.42 to a high of 45.46. The Chemicals industry median EBITDA Margin % is 9.64. Kanchi Karpooram's value of 5.69% is 41% below this industry median. Based on the distribution chart, Kanchi Karpooram ranks #880 out of 1578 companies in the Chemicals industry, which is below the industry midpoint. Overall, Kanchi Karpooram has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kanchi Karpooram's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Kanchi Karpooram ranks #880 out of 1578 companies for EBITDA Margin %. This places Kanchi Karpooram in the lower half of its industry. The industry median EBITDA Margin % is 9.64. Kanchi Karpooram's value of 5.69% is 41% below this benchmark. Historically, Kanchi Karpooram's own EBITDA Margin % has ranged from 2.42 to 45.46 over the past decade. While the company's 10-year median is 16.37 vs. the industry median of 9.64, Kanchi Karpooram has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kanchi Karpooram's current EBITDA Margin % of 5.69% is 41% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kanchi Karpooram and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kanchi Karpooram's current EBITDA Margin % is 5.69%, which is 65% below median its own 10-year median of 16.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kanchi Karpooram stock overvalued right now?
Based on GuruFocus' analysis, Kanchi Karpooram (BOM:538896) is currently considered Fairly Valued. The stock's GF Value™ is ₹379.34, compared to a current price of ₹358.20 — trading 5.6% below its estimated fair value. The current EBITDA Margin % is 5.69%, which is 65% below median its 10-year median of 16.37 and 41% below the Chemicals industry median of 9.64. Kanchi Karpooram's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Kanchi Karpooram (BOM:538896), the current EBITDA Margin % is 5.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kanchi Karpooram (BOM:538896) Overvalued in 2026?
Based on GuruFocus' analysis, Kanchi Karpooram stock appears to be undervalued.
The current stock price of ₹358.20 is trading 5.6% below its estimated GF Value™ of ₹379.34.
GuruFocus considers Kanchi Karpooram to be Fairly Valued.
Key valuation signals for BOM:538896:
EBITDA Margin %: 5.69% (65% below median its 10-year median of 16.37)
GF Value™: ₹379.34 vs. price of ₹358.20 (5.6% below fair value)
Industry Position: 41% below the Chemicals median (#880 of 1578)
No single metric tells the full story. See the BOM:538896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kanchi Karpooram Ltd is engaged in manufacturing Camphor, its derivatives, Gum rosin, Value Added Resins, and Fortified Rosin. Some of the products offered by the company include Camphene, Dipentene, Sodium Acetate Trihydrate Pine Pitch, Double distilled turpentine, and Isobornyl Acetate. The company is engaged in the activity of a single segment that is the manufacture and sale of Camphor and allied products.
73GF Score
Get the complete analysis for BOM:538896
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538896 has been successfully added to your 
